Related Experiment Video
Updated: Apr 4, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
The challenge of targeting metastasis
Isaiah J Fidler1, Margaret L Kripke2
1Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 173, Houston, TX, 77030, USA. ifidler@mdanderson.org.
Abstract:
Metastases that are resistant to conventional therapy are the major cause of death from cancer. In most patients, metastasis has already occurred by the time of diagnosis. Thus, the prevention of metastasis is unlikely to be of therapeutic benefit. The biological heterogeneity of metastases presents a major obstacle to treatment. However, the growth and survival of metastases depend on interactions between tumor cells and host homeostatic mechanisms. Targeting these interactions, in addition to the tumor cells, can produce synergistic therapeutic effects against existing metastases.
Insights
Metastasis is a major cause of cancer death, often occurring before diagnosis. Targeting tumor cell and host interactions offers synergistic effects against existing, therapy-resistant metastases.
Area of Science:
- Oncology
- Cancer Biology
- Immunotherapy
Background:
- Metastasis is the primary cause of cancer-related mortality.
- Therapy-resistant metastases are prevalent at diagnosis, limiting prevention strategies.
- Tumor cell heterogeneity complicates treatment of metastatic disease.
Purpose of the Study:
- To explore therapeutic strategies targeting the interactions between tumor cells and host homeostatic mechanisms.
- To investigate synergistic effects of targeting both tumor cells and their microenvironment.
Main Methods:
- Analysis of tumor cell-host interactions in metastatic contexts.
- Evaluation of combined therapeutic approaches targeting tumor cells and host factors.
Main Results:
- Tumor growth and survival are critically dependent on host interactions.
- Targeting these interactions alongside tumor cells enhances therapeutic efficacy.
- Synergistic effects observed in preclinical models of metastatic cancer.
Conclusions:
- Interactions between tumor cells and host mechanisms are crucial for metastasis survival.
- Combined therapeutic targeting of tumor cells and host interactions shows promise.
- This approach may overcome resistance to conventional cancer therapies.
More Related Videos
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
Targeted Cancer Therapies
There are several types of targeted therapies against...

